Cargando…

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

BACKGROUND: Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be only limitedly explored further for causation because of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807419/ https://www.ncbi.nlm.nih.gov/pubmed/36593440 http://dx.doi.org/10.1186/s12874-022-01760-0

Ejemplares similares

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC
por: Ismail, R. K., et al.
Publicado: (2023)

The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
por: Verschueren, M. V., et al.
Publicado: (2021)

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2021)

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer
por: Ismail, R.K., et al.
Publicado: (2021)

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
por: Ismail, R.K., et al.
Publicado: (2022)

Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer
por: Cramer‐van der Welle, Christine M., et al.
Publicado: (2020)

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis
por: Ismail, Rawa Kamaran, et al.
Publicado: (2022)

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2020)

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2018)

‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer
por: Cramer-van der Welle, Christine M, et al.
Publicado: (2021)

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
por: Mfumbilwa, Zakile A., et al.
Publicado: (2023)

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
por: Ismail, Rawa K., et al.
Publicado: (2022)

Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
por: Donington, Jessica S.
Publicado: (2022)

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases
por: Ismail, Rawa K., et al.
Publicado: (2020)

Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020)

Diverse Modes of Axon Elaboration in the Developing Neocortex
por: Portera-Cailliau, Carlos, et al.
Publicado: (2005)

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
por: Noordhof, Anneloes L., et al.
Publicado: (2023)

Doing philosophy effectively II: A replication and elaboration of student learning in classroom teaching
por: Kienstra, Natascha, et al.
Publicado: (2018)

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
por: Zheng, Juyan, et al.
Publicado: (2020)

Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials
por: van den Hoek, Hester L, et al.
Publicado: (2011)

More elaborate processing of own‐race faces and less elaborate processing of other‐race faces contribute to the other‐race effect in face memory
por: Herzmann, Grit, et al.
Publicado: (2022)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy
por: Adam, Lucas C., et al.
Publicado: (2018)

Detection of bioorthogonal groups by correlative light and electron microscopy allows imaging of degraded bacteria in phagocytes
por: van Elsland, Daphne M., et al.
Publicado: (2016)

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis
por: Ronden, Merle I., et al.
Publicado: (2021)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC
por: Lee, Jay M., et al.
Publicado: (2021)

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
por: Goh, Kah Yee, et al.
Publicado: (2023)

Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer
por: Révész, Dóra, et al.
Publicado: (2019)

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
por: Mouritzen, Mette T., et al.
Publicado: (2021)

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
por: Cohen, Jérémie F, et al.
Publicado: (2016)

CLARIFY 2021: explanation and elaboration of the Delphi-based guidelines for the reporting of yoga research
por: Moonaz, Steffany, et al.
Publicado: (2021)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
por: Janssens, A. Cecile J. W., et al.
Publicado: (2011)

Study design of PerfectFit@Night, a workplace health promotion program to improve sleep, fatigue, and recovery of night shift workers in the healthcare sector
por: van Elk, Fleur, et al.
Publicado: (2022)

Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?
por: Baardman, R., et al.
Publicado: (2020)

Extra-pair paternity drives plumage colour elaboration in male passerines
por: Thibault, Emma, et al.
Publicado: (2022)

Narrative elaboration makes misinformation and corrective information regarding COVID-19 more believable
por: Greer, Joanna, et al.
Publicado: (2022)

Oorlogswinstmakers
por: VAN DARTEL, HANS
Publicado: (2021)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o07kcqklruufbbk5snmvojl3ho